Found vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
MEDVi beats Found overall, scoring 7.7/10 vs 7.3/10. Found is more affordable at $129/mo vs $179/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side look at Found and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Found
#33 of 53Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.
Visit FoundMEDVi
#18 of 53MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDVi| Feature | Found | MEDVi |
|---|---|---|
| Why each one | One of the only GLP-1 platforms that actively coordinates with insurance companies, offers a GLP-1 coverage check, and prescribes from 10+ medications. | The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients. |
| Our Score | 7.3/10 | 7.7/10 |
| Starting Price | $129/mo | $179/mo |
| Medication Type | Both | Both |
| Insurance Accepted | Yes | No |
| Best For | Insured patients who want their GLP-1 coverage checked and their copay minimized | Users who want a low entry price with oral and injectable compounded options |
| Watch out for | Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying | No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only) |
| Ranking | #33 | #18 |
| Get started | Visit Found | Visit MEDVi |
Pros & Cons Compared
Found
Pros
- +Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
- +10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
- +Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
- +Most members start treatment within one week of completing the health questionnaire
Cons
- −Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
- −The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
- −Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
Our Verdict
MEDVi edges out Found with a score of 7.7/10 vs 7.3/10. If budget is your priority, Found is from $129/mo compared to MEDVi at $179/mo for the first month, then $299/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.
Cheapest in our index
Embody
$69/mo flat rate · 7.3/10 · Compounded
Both Found and MEDVi start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
Other matchups readers comparing Found or MEDVi tend to look at next.
- Found vs Oak Longevity$119/mo
- Found vs Eden Health GLP-1$249/mo
- Found vs Lemonaid Health$129/mo
- MEDVi vs Shed$199/mo
- MEDVi vs AgelessRx$199/mo
- MEDVi vs Hers$199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: MEDVi · 7.7/10